DE69229070T2 - Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation - Google Patents

Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation

Info

Publication number
DE69229070T2
DE69229070T2 DE69229070T DE69229070T DE69229070T2 DE 69229070 T2 DE69229070 T2 DE 69229070T2 DE 69229070 T DE69229070 T DE 69229070T DE 69229070 T DE69229070 T DE 69229070T DE 69229070 T2 DE69229070 T2 DE 69229070T2
Authority
DE
Germany
Prior art keywords
inhalation
acetylsalicylic acid
antireactive
drugs
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69229070T
Other languages
English (en)
Other versions
DE69229070D1 (de
Inventor
Sebastiano Bianco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B S D BIO SCIENCE DEV SNC DI O
Original Assignee
B S D BIO SCIENCE DEV SNC DI O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B S D BIO SCIENCE DEV SNC DI O filed Critical B S D BIO SCIENCE DEV SNC DI O
Application granted granted Critical
Publication of DE69229070D1 publication Critical patent/DE69229070D1/de
Publication of DE69229070T2 publication Critical patent/DE69229070T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
DE69229070T 1991-02-09 1992-02-06 Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation Expired - Lifetime DE69229070T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91101818 1991-02-09

Publications (2)

Publication Number Publication Date
DE69229070D1 DE69229070D1 (de) 1999-06-10
DE69229070T2 true DE69229070T2 (de) 1999-11-18

Family

ID=8206393

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229070T Expired - Lifetime DE69229070T2 (de) 1991-02-09 1992-02-06 Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation

Country Status (16)

Country Link
US (1) US6051566A (de)
JP (1) JPH0648958A (de)
KR (1) KR920016086A (de)
AT (1) ATE179605T1 (de)
AU (1) AU662509B2 (de)
BR (1) BR9200429A (de)
CA (1) CA2060937A1 (de)
CZ (1) CZ281970B6 (de)
DE (1) DE69229070T2 (de)
HU (1) HUT60917A (de)
IE (1) IE920427A1 (de)
IL (1) IL100896A (de)
MX (1) MX9200571A (de)
NO (1) NO179893C (de)
NZ (1) NZ241542A (de)
ZA (1) ZA92890B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
MXPA02001323A (es) 2000-05-10 2004-07-16 Alliance Pharma Microgranulos con base fosfolipida para la liberacion de farmaco.
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6613308B2 (en) * 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US7256184B2 (en) * 2000-10-16 2007-08-14 Rodriguez Victorio C Treatment of aging disorders in humans
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US7078016B2 (en) 2001-11-21 2006-07-18 Alexza Pharmaceuticals, Inc. Delivery of caffeine through an inhalation route
ATE415155T1 (de) * 2001-05-24 2008-12-15 Alexza Pharmaceuticals Inc Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation
WO2002094246A2 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
JP2005503425A (ja) * 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
US6805853B2 (en) * 2001-11-09 2004-10-19 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
WO2002094242A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of rizatriptan or zolmitriptan through an inhalation route
US20030144219A1 (en) 2001-11-15 2003-07-31 Phinney Stephen Dodge Formulations and methods for treatment or amelioration of inflammatory conditions
CA2468958C (en) 2001-12-19 2012-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
EP1503744A1 (de) 2002-05-13 2005-02-09 Alexza Molecular Delivery Corporation Verabreichung von aminenhaltigen arzneistoffen durch inhalation
US20060193788A1 (en) * 2002-11-26 2006-08-31 Hale Ron L Acute treatment of headache with phenothiazine antipsychotics
CA2507158A1 (en) * 2002-11-26 2004-06-10 Alexza Molecular Delivery Corporation Treatment of headache with antipsychotics delivered by inhalation
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
JP2006514934A (ja) * 2002-11-26 2006-05-18 アレックザ ファーマシューティカルズ， インコーポレイテッド 疼痛治療用薬剤製造のためのロキサピンまたはアモキサピンの使用
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
ATE510174T1 (de) 2003-05-21 2011-06-15 Alexza Pharmaceuticals Inc Schlag gezündete unabhängige heizeinheit
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US8455437B2 (en) * 2005-02-04 2013-06-04 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Method to predict and prevent oxygen-induced inflammatory tissue injury
ITMI20050417A1 (it) * 2005-03-15 2006-09-16 Medestea Res & Production S R L Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica
WO2007095039A2 (en) * 2006-02-09 2007-08-23 Schering Corporation Pharmaceutical formulations
JP5094197B2 (ja) * 2006-04-27 2012-12-12 第一三共ヘルスケア株式会社 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
DE102008004386A1 (de) * 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
CA2722668A1 (en) * 2008-04-29 2009-11-05 Wyeth Llc Methods for treating inflammation
KR101704815B1 (ko) * 2009-08-21 2017-02-09 포항공과대학교 산학협력단 Ｉｌ－１７ 매개 염증질환의 치료를 위한 조합 제제 및 이를 이용한 치료 방법
US20130281405A1 (en) * 2012-04-02 2013-10-24 Lenard M. Lichtenberger Use of pc-nsaids to treat and/or prevent pulmonary inflammation
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
JP2016518388A (ja) * 2013-04-30 2016-06-23 オティトピック インク． 乾燥粉末配合および使用方法
TWI586383B (zh) * 2014-04-18 2017-06-11 林信湧 一種用於治療關節炎之吸入式醫藥組成物及其備製方法
EP3191091B1 (de) 2014-09-12 2020-08-26 Children's Medical Center Corporation Formulierungen einer diätetischen emulsion und verfahren zur verwendung davon
WO2016196401A1 (en) * 2015-05-29 2016-12-08 The Texas A&M University System Antimicrobial and anti-inflammatory compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244899A (en) * 1985-02-04 1993-09-14 G. D. Searle And Co. Azabicycloalkyl and azatricycloalkyl amides used to treat inflammation, allergy, asthma and skin disorders
US4885287A (en) * 1988-08-09 1989-12-05 University Of Kentucky Research Foundation Novel method of administering aspirin and dosage forms containing same

Also Published As

Publication number Publication date
NZ241542A (en) 1996-05-28
NO920504D0 (no) 1992-02-07
AU1077292A (en) 1992-08-13
MX9200571A (es) 1992-12-01
JPH0648958A (ja) 1994-02-22
IL100896A (en) 1998-02-22
CA2060937A1 (en) 1992-08-10
IL100896A0 (en) 1992-11-15
CZ281970B6 (cs) 1997-04-16
NO179893B (no) 1996-09-30
NO179893C (no) 1997-01-08
HU9200389D0 (en) 1992-04-28
DE69229070D1 (de) 1999-06-10
ATE179605T1 (de) 1999-05-15
NO920504L (no) 1992-08-10
AU662509B2 (en) 1995-09-07
IE920427A1 (en) 1992-08-12
HUT60917A (en) 1992-11-30
CS35292A3 (en) 1992-08-12
KR920016086A (ko) 1992-09-24
ZA92890B (en) 1992-12-30
US6051566A (en) 2000-04-18
BR9200429A (pt) 1992-10-13

Similar Documents

Publication Publication Date Title
DE69229070D1 (de) Antireaktive antiasthmatische Wirkung von Acetylsalicylsäure durch Inhalation
TR199500856A2 (tr) Nefesle ice cekilerek alinan farmasötik bilesim.
ES2162865T3 (es) Composiciones para inhalacion.
DE3581819D1 (de) Pyridazinamine wirksam gegen viren.
IE862554L (en) Pharmaceutical compositions
SE8305485L (sv) Galeniska kompositioner innefattande kalcitonin och deras anvendning
BR0110139A (pt) Formulações farmacêuticas para inaladores de pó seco
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
EP0919229A3 (de) Antireaktiver und antiasthmatischer Aktivität von inhalierte nichtsteroidale Entzündungshemmer
JPS5781409A (en) External plaster
PT805157E (pt) Derivados do indole e sua utilizacao medicinal
GB1294681A (en) Novel bis-thiachromonyl compounds their preparation and use
JPS57114518A (en) Hypotensive agent
IT8948578A0 (it) Impiego di farmaci anti-infiammatori non steroidei in generale ed in particolare l'acido tiaprofenico, comunemente chiamati fans, in soluzione per applicazione topica sotto forma di spray, realizzato connebulizzatore senza uso di propellenti gassosi.
JPS57105423A (en) Chloroethylureidopropylpolysilsesquioxane
TH21055A (th) สารผสมทางเภสัชศาสตร์สำหรับดำเนินการโดยการสูดดม
TH109999A3 (th) นิวคลีโอไซด์
IT1241515B (it) Sali dell'acido nicotinico con composti aminobenzilici e loro impiego farmaceutico".
JPS55133313A (en) Cholesterol-lowering agent

Legal Events

Date Code Title Description
8364 No opposition during term of opposition